Evidence Based Review on Daptomycin Use in the Treatment of Gram(+) Infections
Daptomycin is the only clinically used member of a cyclic lipopeptides class of antibiotics. Daptomycin has rapid bactericidal activity against not only rapidly growing, but also against slow growing bacterial cells including those in biofilms. Spectrum of daptomycin’s activity includes almost all c...
Main Authors: | Popov D.A., Zubareva N.A., Dekhnich A.V. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2016-11-01
|
Series: | Клиническая микробиология и антимикробная химиотерапия |
Subjects: | |
Online Access: | https://cmac-journal.ru/publication/2016/4/cmac-2016-t18-n4-p270/cmac-2016-t18-n4-p270.pdf |
Similar Items
-
Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections
by: Artur Timerman, et al. -
Daptomycin Experience Between Years 2009-2013: Review of 139 Cases
by: Aslıhan CANDEVİR ULU, et al.
Published: (2014-12-01) -
Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
by: Maddalena Peghin, et al.
Published: (2019-08-01) -
Daptomycin in the treatment of infective endocarditis
by: Popov D.A.
Published: (2018-02-01) -
Daptomycin in left-sided endocarditis: A single center experience
by: Burak Açar, et al.
Published: (2017-06-01)